| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0007 | 1 |